BD 515053 - Injector Closed Transfer System, 250/CA

BD 515053 - Injector Closed Transfer System, 250/CA

The BD 515053 Injector Closed Transfer System is a specialized closed system drug transfer device designed to help protect healthcare professionals from exposure to hazardous medications during drug preparation and administration. Manufactured by Becton, Dickinson and Company, this injector component maintains a sealed drug pathway, helping prevent the escape of aerosols, vapors, and liquid contaminants.

Designed for use in high-risk medication environments, the injector plays a critical role in closed system workflows by enabling safe syringe access while preserving system integrity. It supports modern safety standards in oncology, pharmacy, and infusion settings where occupational exposure control is essential.

Key Benefits

The BD 515053 Injector helps reduce the risk of hazardous drug exposure by maintaining a closed connection during syringe-based drug transfer. Its design supports safe, controlled handling without compromising accuracy or efficiency.

The injector integrates smoothly into closed system workflows, allowing clinicians to prepare and administer medications with confidence. Its single-use design supports infection control protocols and eliminates the need for cleaning or reprocessing.

Compatibility and Applications

This injector is designed for compatibility with BD closed transfer system components used in hazardous drug handling. It is commonly used in conjunction with syringes and vial access devices within closed system setups.

Typical applications include chemotherapy preparation, biologic drug handling, and administration of other hazardous medications in hospital pharmacies, oncology units, infusion centers, and sterile compounding environments.

Usage Guidelines

The BD 515053 Injector Closed Transfer System should be used in accordance with institutional hazardous drug handling procedures. Healthcare professionals should confirm compatibility with other closed system components prior to use.

Aseptic technique must be followed throughout preparation and administration. After use, the injector should be disposed of according to facility policy and hazardous waste regulations. The device is intended for single use only.

Certifications, Safety Standards, and Regulatory Approvals

This product is manufactured under strict quality management systems aligned with FDA medical device regulations and internationally recognized manufacturing standards. These controls help ensure consistent performance, reliable sealing, and material integrity.

Regulatory compliance supports the injectors use in regulated healthcare environments and reinforces its role in occupational safety and exposure prevention programs.

Comparison with Competitor Products

Compared with open syringe transfer methods or partial containment devices, the BD 515053 Injector Closed Transfer System provides a higher level of exposure protection by maintaining a fully closed pathway. While some competitor systems offer limited sealing, BD closed transfer components are widely trusted for consistent containment and workflow integration.

Healthcare facilities often select BD closed system injectors due to their dependable performance, ease of use, and alignment with evolving hazardous drug safety expectations.

Typical User Profile and Application Scenarios

Typical users include pharmacists, pharmacy technicians, oncology nurses, and other trained healthcare professionals responsible for preparing or administering hazardous medications.

The injector is most effective in hospital pharmacies, oncology clinics, infusion centers, and sterile compounding rooms where minimizing occupational exposure and maintaining regulatory compliance are critical priorities.

Best Practices for Use and Maintenance

Best practice includes proper staff training on closed system drug transfer techniques and verification of correct component compatibility prior to use. The injector should remain in its packaging until immediately before use to preserve integrity.

After completion of drug transfer or administration, the injector should be disposed of promptly according to hazardous waste handling protocols. As a single-use device, no maintenance or reprocessing is required.

Regulatory and Safety Information

The BD 515053 Injector Closed Transfer System is classified as a regulated medical device and complies with applicable FDA requirements. Its use supports adherence to hazardous drug handling guidelines and occupational safety recommendations commonly enforced in healthcare settings.

Following manufacturer instructions and institutional policies ensures safe, compliant use while protecting healthcare personnel from unnecessary exposure.

How to Order

The BD 515053 Injector Closed Transfer System is available for purchase through the CIA Medical website. Add the product to your cart and proceed through the secure checkout process.

For bulk orders, institutional pricing, or additional assistance, contact CIA Medical customer service at 312 275 5850 or use the contact form available on this page for prompt support.